Thambi Dorai - Concepedia

Author

Thambi Dorai

New York Medical College ORCID

Also Known As

T Dorai, T. Dorai, THAMBI DORAI, Thambi Dorai

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

New York Medical College Columbia University Lady of Mercy Medical Center Icahn School of Medicine at Mount Sinai Mercy Medical Center

About

Thambi Dorai is an author at New York Medical College specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	700
2	Cell Biology	7	7	250
3	Natural Sciences	6	6	329
4	Biochemistry	4	4	310
5	Cellular Physiology	4	4	198

Thambi Dorai

Publications

Citations

H-Index

Page 1

	Year	Citations
Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo Thambi Dorai, Yichen Cao, Bhuvaneswari Dorai, The Prostate	2001	323
The role of carbonic anhydrase IX overexpression in kidney cancer Thambi Dorai, Ihor S. Sawczuk, Jaromı́r Pastorek, European Journal of Cancer UrologyRenal FunctionBiochemistryRenal PathologyRenal Inflammation	2005	164
TRANSDIFFERENTIATION OF PROSTATE CANCER CELLS TO A NEUROENDOCRINE CELL PHENOTYPE IN VITRO AND IN VIVO Tatjana Burchardt, Martin Burchardt, Min‐Wei Chen, The Journal of Urology	1999	163
The structurally distinct form of pp60c-src detected in neuronal cells is encoded by a unique c-src mRNA. Joan Levy, Thambi Dorai, L H Wang, Molecular and Cellular Biology Signal RecognitionMolecular BiologyCellular NeurobiologyCellular PhysiologyEmbryology	1987	134
Therapeutic potential of curcumin in human prostate cancer—I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells Thambi Dorai, N Gehani, Aaron E. Katz Prostate Cancer and Prostatic Diseases Human Prostate Cancer—iTherapeutic PotentialUrologyChemoprevention StrategyMedicine	2000	125
Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Thambi Dorai, N Gehani, Aaron E. Katz PubMed	2000	116
Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. Hiroyuki Kobayashi, Thambi Dorai, J F Holland, PubMed Molecular BiologyMultidrug-resistant Tumor CellsChemical BiologyTumor BiologyProtein Synthesis	1994	110
Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium Ruoqian Shen, Thambi Dorai, Matthias Szaboles, Urologic Oncology Seminars and Original Investigations	1997	108
Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer Thambi Dorai, Carl A. Olsson, Aaron E. Katz, The Prostate	1997	86
Therapeutic potential of curcumin in prostate cancer—IV: Interference with the osteomimetic properties of hormone refractory C4‐2B prostate cancer cells Thambi Dorai, Janice P. Dutcher, David W. Dempster, The Prostate	2003	61

Page 1